在免疫检查点抑制剂治疗中研究非编码RNA的机制
Jie Bian1, Rui Shao2, Juan Li1
1Department of Oncology, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
Cancer science
|August 13, 2024
概括
非编码RNAs (ncRNAs) 调节编程死亡1/编程细胞死亡-连接体1 (PD-1/PD-L1) 轴,影响瘤免疫疗法的疗效. 了解这些ncRNA机制可以增强各种癌症的免疫检查点抑制剂 (ICI) 治疗.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫检查点抑制剂 (ICI) 疗法具有高特异性和低副作用,显著促进癌症治疗.
- 编程死亡1/编程细胞死亡-连接体1 (PD-1/PD-L1) 轴对瘤免疫逃避至关重要,也是免疫治疗的主要标.
- 非编码RNAs (ncRNAs) 越来越多地被认为是它们在调节瘤免疫微环境中的作用.
研究的目的:
- 阐明ncRNAs调节PD-1/PD-L1轴的机制.
- 探索ncRNAs如何通过调节PD-L1表达来影响ICI治疗的疗效.
- 为开发更有效的针对各种癌症的免疫疗法提供见解.
主要方法:
- 文献综述侧重于研究PD-1/PD-L1轴的ncRNA调节的研究.
- 分析将ncRNA与PD-L1表达和免疫检查点功能联系起来的分子机制.
- 对ncRNA对瘤免疫微环境和ICI反应的影响的当前知识的综合.
主要成果:
- 已证实ncRNAs可以调节瘤免疫微环境中的PD-1/PD-L1轴表达.
- 特定的ncRNA可以增强或减少ICI治疗的有效性.
- 这些ncRNAs的调节作用对于瘤的产生,发育和对免疫治疗的反应至关重要.
结论:
- ncRNAs代表了癌症免疫治疗中PD-1/PD-L1轴的关键调节因素.
- 针对ncRNA介导的PD-1/PD-L1调节提供了一个有希望的战略,以优化ICI治疗.
- 对ncRNA功能的进一步研究可以导致改进和更个性化的癌症免疫疗法.
相关概念视频
02:15Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
01:23RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K
02:39lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K
02:30siRNA - Small Interfering RNAs
16.7K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.7K
01:27Tumor Immunotherapy
497
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
497
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K